<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-182 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-182</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-182</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-7.html">extraction-schema-7</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <p><strong>Paper ID:</strong> paper-4175439bd80808c0797af0c3d203747f0003704a</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/4175439bd80808c0797af0c3d203747f0003704a" target="_blank">TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease</a></p>
                <p><strong>Paper Venue:</strong> Annals of Neurology</p>
                <p><strong>Paper TL;DR:</strong> This study aimed to determine the frequency of frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD‐U) in the setting of hippocampal sclerosis and Alzheimer's disease using immunohistochemistry for TAR DNA binding protein 43 (TDP‐43), a putative marker for FTLD‐ U.</p>
                <p><strong>Cost:</strong> 0.013</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e182.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e182.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>CA1/subiculum pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Hippocampal CA1 and subiculum pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Principal excitatory neurons of the hippocampal formation (CA1 and subiculum) that define the region affected in hippocampal sclerosis and that show frequent TDP-43 pathology in AD and HpScl.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>TDP-43 IMMUNOREACTIVITY IN HIPPOCAMPAL SCLEROSIS AND ALZHEIMER'S DISEASE</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Hippocampal pyramidal neurons (CA1 and subiculum)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>HpScl is defined by neuronal loss in CA1 and subiculum; TDP-43 immunoreactivity (neuronal cytoplasmic and intranuclear inclusions and neurites) was detected in the majority (>70%) of HpScl cases and in many AD cases with HpScl, indicating these neurons are vulnerable to TDP-43 pathology.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Pathologic cytoplasmic mislocalization of normally nuclear TDP-43, presence of abnormal phosphorylated and higher molecular-weight TDP-43 species on Western blots, and a proposed propensity for co-deposition with tau (i.e., regional vulnerability and possible tau-triggered deposition); hypothesis that TDP-43 may bind RNA in NFTs is also raised.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem brain neuropathology (immunohistochemistry, confocal microscopy, immunoelectron microscopy, biochemistry) from AD and hippocampal sclerosis cases.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Mostly advanced/late Alzheimer-type pathology (many cases with high Braak NFT stage; HpScl diagnosis often in elderly cases)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Not all HpScl or CA1/subiculum neuronal loss is TDP-43–positive (some HpScl attributed to hypoxic-ischemic injury lacked TDP-43); TDP-43 association with tau filaments was occasional and ambiguous (could be granular material associated with filaments rather than TDP-43 in filaments).</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease", 'publication_date_yy_mm': '2007-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e182.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e182.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Dentate granule neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Dentate gyrus granule neurons (dentate fascia)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Granule cells of the dentate gyrus that were repeatedly observed to contain TDP-43 immunoreactive cytoplasmic inclusions and neurites in AD and HpScl cases.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>TDP-43 IMMUNOREACTIVITY IN HIPPOCAMPAL SCLEROSIS AND ALZHEIMER'S DISEASE</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Dentate gyrus granule neurons</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>TDP-43 immunoreactivity was detected in neuronal inclusions in the dentate fascia in all cases that showed TDP-43 pathology; lesions were morphologically similar to FTLD-U inclusions.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>As above: cytoplasmic mislocalization of TDP-43, abnormal phosphorylated TDP-43 species indicating pathologic conformers; regional vulnerability of limbic neurons may reflect propensity for co-deposition with tau or binding to RNA in NFT-containing neurons.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem tissue (immunohistochemistry, confocal, immuno-EM, biochemistry).</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Mostly advanced/late AD pathology (cases studied largely had high Braak stage or HpScl)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Some AD cases lacked TDP-43 in dentate gyrus; TDP-43 sometimes present as NFT-associated staining in other contexts, suggesting heterogeneity in lesion type and distribution.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease", 'publication_date_yy_mm': '2007-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e182.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e182.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Entorhinal cortex neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Entorhinal cortex pyramidal neurons</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Layer II/III and other pyramidal neurons of the entorhinal cortex frequently showing TDP-43 immunoreactive inclusions and neurites in AD and HpScl cases.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>TDP-43 IMMUNOREACTIVITY IN HIPPOCAMPAL SCLEROSIS AND ALZHEIMER'S DISEASE</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Entorhinal cortical neurons</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>TDP-43 inclusions and neurites were consistently present in the entorhinal cortex in cases with TDP-43 pathology; confocal microscopy showed more co-localization of TDP-43 with phospho-tau in entorhinal cortex than in dentate gyrus.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Regional vulnerability of limbic neurons; possible interaction between tau pathology and TDP-43 deposition (tau may trigger TDP-43 deposition), and TDP-43's RNA-binding properties that could mediate interaction with RNA-rich NFTs.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem neuropathological analyses (IHC, IF confocal, IEM, biochemistry).</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Predominantly late/advanced AD (many cases with Braak stages IV–VI)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Co-localization patterns vary: TDP-43 and phospho-tau sometimes occupy distinct inclusions in the same neuron rather than overlapping, and not all entorhinal NFTs or neurons show TDP-43.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease", 'publication_date_yy_mm': '2007-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e182.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e182.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Amygdala neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Amygdala neurons (limbic neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Neurons of the amygdala that showed consistent involvement by TDP-43 immunoreactive inclusions in AD cases with TDP-43 pathology.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>TDP-43 IMMUNOREACTIVITY IN HIPPOCAMPAL SCLEROSIS AND ALZHEIMER'S DISEASE</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Amygdala neurons</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>The amygdala was consistently involved in cases with TDP-43 pathology; TDP-43 immunoreactivity (neuronal inclusions/neurites) was frequently detected there across affected AD and HpScl cases.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Limbic-predominant regional vulnerability, potential facilitation of TDP-43 deposition by local tau pathology (analogy to tau–α-synuclein co-deposition), and RNA-binding properties of TDP-43 that could relate to RNA-rich inclusions.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem neuropathology (IHC, regional scoring across brain areas).</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Mostly advanced/late AD pathology (limbic-predominant involvement noted in cases studied)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Distribution varies between 'limbic' and 'diffuse' types; some cases show limited involvement confined to hippocampus/entorhinal cortex while others show amygdala plus wider cortical involvement.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease", 'publication_date_yy_mm': '2007-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e182.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e182.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Cingulate gyrus neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Cingulate gyrus neurons (limbic association cortex)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Neurons in the cingulate gyrus that can be affected by TDP-43 inclusions, particularly in cases with 'diffuse' TDP-43 pathology.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>TDP-43 IMMUNOREACTIVITY IN HIPPOCAMPAL SCLEROSIS AND ALZHEIMER'S DISEASE</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Cingulate gyrus neurons</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible (in diffuse cases)</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Cingulate gyrus involvement was more frequent and more severe in AD cases classified as 'diffuse' TDP-43 type than in 'limbic' type; diffuse cases had significantly higher cingulate scores.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Extent of process/severity-related spread from limbic structures; not specific molecular mechanism identified beyond association with TDP-43 pathological conformers and potential tau interaction.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem brain immunohistochemistry with semi-quantitative regional scoring.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Unspecified/varies; diffuse involvement associated with more severe/widespread pathology (later stage or more advanced pathology)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Many TDP-43–positive cases are limbic-limited and lack cingulate involvement; presence is thus context- and severity-dependent.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease", 'publication_date_yy_mm': '2007-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e182.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e182.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Nucleus accumbens neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neurons of the nucleus accumbens</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Ventral striatal neurons that were variably affected by TDP-43 inclusions, more commonly in diffuse-type cases.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>TDP-43 IMMUNOREACTIVITY IN HIPPOCAMPAL SCLEROSIS AND ALZHEIMER'S DISEASE</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>Nucleus accumbens neurons</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible (in diffuse cases)</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>Median nucleus accumbens TDP-43 score was significantly higher in diffuse-type cases compared to limbic-type (median 1 vs 0.5, p<0.05), indicating vulnerability in more widespread disease.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Likely related to spread/severity of TDP-43 pathology rather than a cell-type–specific protective mechanism; possible interactions with tau pathology and abnormal TDP-43 conformers.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem immunohistochemistry and semi-quantitative scoring across regions.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Associated with more diffuse/more severe pathology (later or more severe cases)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>Often spared in limbic-type cases; involvement is not universal and depends on extent ('limbic' vs 'diffuse').</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease", 'publication_date_yy_mm': '2007-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e182.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e182.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of specific cell types in Alzheimer's disease that are described as susceptible or resilient, the evidence for this classification, and any proposed mechanisms or factors explaining their susceptibility or resilience.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>NFT-bearing neurons</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Neurons containing neurofibrillary tangles (NFT-bearing neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Neurons that contain tau-positive neurofibrillary tangles; a subset of these NFTs in AD showed TDP-43 immunoreactivity (either overlapping or as separate inclusions within the same neuron).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>TDP-43 IMMUNOREACTIVITY IN HIPPOCAMPAL SCLEROSIS AND ALZHEIMER'S DISEASE</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>cell_type</strong></td>
                            <td>NFT-bearing neurons (tau-positive neurons)</td>
                        </tr>
                        <tr>
                            <td><strong>susceptibility_status</strong></td>
                            <td>susceptible (subset show TDP-43 association)</td>
                        </tr>
                        <tr>
                            <td><strong>evidence_for_status</strong></td>
                            <td>In AD cases without FTLD-U–type inclusions, occasional NFTs in subiculum and entorhinal cortex had TDP-43 immunoreactivity (NFT-like TDP-43 found in ~14% of such cases); frequency of NFT-like TDP-43 correlated with Braak NFT stage (r=0.24, p=0.01).</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanisms</strong></td>
                            <td>Hypothesis that tau pathology may trigger deposition of TDP-43 (analogy to tau–α-synuclein synergy); TDP-43 is an RNA-binding protein and may bind RNA sequestered in NFTs; pathological phosphorylation and higher-MW TDP-43 species suggest post-translational modification promotes aggregation.</td>
                        </tr>
                        <tr>
                            <td><strong>experimental_context</strong></td>
                            <td>Human postmortem immunohistochemistry, confocal double-labeling (TDP-43 and phospho-tau), immuno-EM, biochemistry.</td>
                        </tr>
                        <tr>
                            <td><strong>disease_stage</strong></td>
                            <td>Correlated with Braak NFT stage (i.e., more frequent in later/more advanced stages)</td>
                        </tr>
                        <tr>
                            <td><strong>contradictory_findings</strong></td>
                            <td>FTLD-U–type TDP-43 inclusions (neuritic and cytoplasmic) did not correlate with Braak stage, indicating two distinct phenomena (NFT-associated TDP-43 versus FTLD-U–like TDP-43); in many NFTs TDP-43 was absent and co-localization was often partial or separate inclusions.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': "TDP‐43 immunoreactivity in hippocampal sclerosis and Alzheimer's disease", 'publication_date_yy_mm': '2007-05'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis <em>(Rating: 2)</em></li>
                <li>TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis <em>(Rating: 2)</em></li>
                <li>Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia <em>(Rating: 2)</em></li>
                <li>Sequestration of RNA in Alzheimer's disease neurofibrillary tangles and senile plaques <em>(Rating: 1)</em></li>
                <li>Initiation and synergistic fibrillization of tau and alpha-synuclein <em>(Rating: 1)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>